Literature DB >> 16227107

Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.

Naila Usmani1, Graeme I Stables, Nick R Telfer, Mark R Stringer.   

Abstract

A 66-year-old man presented with an 18-month history of progressive nail dystrophy involving his left index finger. A diagnostic biopsy specimen confirmed the clinical suggestion of subungual Bowen's disease (carcinoma in situ). Various treatment options were considered, and the decision was made to treat with photodynamic therapy using topical 5-aminolevulunic acid administered as two treatments 4 weeks apart. The patient was reviewed 3 months after treatment and then regularly at 6-month intervals. Thirty months after treatment there remained no clinical evidence of recurrence of the condition with preservation of a normal nail unit. Although the successful treatment of cutaneous Bowen's disease with photodynamic therapy is well documented, this is the first report of the successful treatment of subungual Bowen's disease using topical aminolevulunic acid-photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227107     DOI: 10.1016/j.jaad.2005.03.056

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Recent advances in the prevention and treatment of skin cancer using photodynamic therapy.

Authors:  Baozhong Zhao; Yu-Ying He
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

2.  Bowen's disease - a review of newer treatment options.

Authors:  Thorsten Neubert; Percy Lehmann
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

3.  Aggressive curettage-cryosurgery for human papillomavirus-16 associated subungual squamous cell carcinoma in situ.

Authors:  Peter Nordin; Bo Clarence Stenquist
Journal:  J Cutan Aesthet Surg       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.